Zhejiang Hisoar Pharmaceutical Co Ltd (002099) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.48 Million ≈ $2.27 Million USD) by net assets (CN¥5.11 Billion ≈ $747.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Hisoar Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Zhejiang Hisoar Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Zhejiang Hisoar Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.

Zhejiang Hisoar Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Hisoar Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Innovative Medical Management Co Ltd
SHE:002173
-0.007x
Ruentex Industries Ltd
TW:2915
-0.001x
Greatech Technology Bhd
KLSE:0208
0.042x
SoftwareONE Holding AG
SW:SWON
0.171x
Zhejiang Shaoxing RuiFeng Rural Commercial Bank Co Ltd
SHG:601528
-0.086x
Dalian Zeus Entertainment
SHE:002354
-0.005x
China Yuchai International Limited
NYSE:CYD
N/A
Healthcare Services Group Inc
NASDAQ:HCSG
0.116x

Annual Cash Flow Conversion Efficiency for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Hisoar Pharmaceutical Co Ltd (002099) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥5.13 Billion
≈ $750.95 Million
CN¥174.83 Million
≈ $25.58 Million
0.034x -20.66%
2023-12-31 CN¥5.60 Billion
≈ $819.71 Million
CN¥240.54 Million
≈ $35.20 Million
0.043x +125.81%
2022-12-31 CN¥6.10 Billion
≈ $893.34 Million
CN¥116.09 Million
≈ $16.99 Million
0.019x +13.58%
2021-12-31 CN¥6.11 Billion
≈ $894.62 Million
CN¥102.36 Million
≈ $14.98 Million
0.017x -81.65%
2020-12-31 CN¥5.85 Billion
≈ $856.34 Million
CN¥533.87 Million
≈ $78.12 Million
0.091x -14.72%
2019-12-31 CN¥5.72 Billion
≈ $837.67 Million
CN¥612.40 Million
≈ $89.61 Million
0.107x -27.14%
2018-12-31 CN¥5.39 Billion
≈ $788.81 Million
CN¥791.45 Million
≈ $115.81 Million
0.147x +635.28%
2017-12-31 CN¥5.14 Billion
≈ $752.44 Million
CN¥102.68 Million
≈ $15.02 Million
0.020x -84.87%
2016-12-31 CN¥4.77 Billion
≈ $698.05 Million
CN¥629.42 Million
≈ $92.10 Million
0.132x +2.00%
2015-12-31 CN¥3.57 Billion
≈ $522.81 Million
CN¥462.16 Million
≈ $67.63 Million
0.129x +114.65%
2014-12-31 CN¥3.18 Billion
≈ $465.15 Million
CN¥191.56 Million
≈ $28.03 Million
0.060x -37.33%
2013-12-31 CN¥632.80 Million
≈ $92.60 Million
CN¥60.85 Million
≈ $8.90 Million
0.096x -60.73%
2012-12-31 CN¥738.05 Million
≈ $108.00 Million
CN¥180.73 Million
≈ $26.45 Million
0.245x +94.84%
2011-12-31 CN¥736.96 Million
≈ $107.84 Million
CN¥92.62 Million
≈ $13.55 Million
0.126x -55.67%
2010-12-31 CN¥638.04 Million
≈ $93.36 Million
CN¥180.88 Million
≈ $26.47 Million
0.283x +61.88%
2009-12-31 CN¥561.79 Million
≈ $82.21 Million
CN¥98.38 Million
≈ $14.40 Million
0.175x +213.25%
2008-12-31 CN¥547.50 Million
≈ $80.12 Million
CN¥30.61 Million
≈ $4.48 Million
0.056x -41.18%
2007-12-31 CN¥538.06 Million
≈ $78.73 Million
CN¥51.14 Million
≈ $7.48 Million
0.095x -20.24%
2006-12-31 CN¥519.27 Million
≈ $75.99 Million
CN¥61.88 Million
≈ $9.06 Million
0.119x -39.55%
2005-12-31 CN¥182.96 Million
≈ $26.77 Million
CN¥36.07 Million
≈ $5.28 Million
0.197x -38.55%
2004-12-31 CN¥132.03 Million
≈ $19.32 Million
CN¥42.36 Million
≈ $6.20 Million
0.321x +600.11%
2003-12-31 CN¥85.03 Million
≈ $12.44 Million
CN¥-5.45 Million
≈ $-798.23K
-0.064x --

About Zhejiang Hisoar Pharmaceutical Co Ltd

SHE:002099 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.50 Billion
CN¥10.26 Billion CNY
Market Cap Rank
#7380 Global
#1762 in China
Share Price
CN¥6.34
Change (1 day)
-3.65%
52-Week Range
CN¥5.05 - CN¥8.83
All Time High
CN¥11.31
About

Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical… Read more